Sodium Chloride (NaCl) 0.9 %

DRUG5 trials

Conditions

Acute Myocardial InfarctionAcute Postoperative PainAllergiesChronic Obstructive Pulmonary Disease (COPD)Iron DeficiencyPulmonary HypertensionSCDVaso Occlussive Crisis

Phase 2

Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction

CompletedNCT00650143

Ludwig-Maximilians - University of MunichAcute Myocardial Infarction

Start: 2008-03-31End: 2013-06-30Updated: 2022-08-25

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

RecruitingNCT07059091

Johns Hopkins UniversityAllergies, Chronic Obstructive Pulmonary Disease (COPD)

Start: 2026-02-12End: 2031-05-01Target: 334Updated: 2026-02-17

Phase 4

The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension

RecruitingNCT07359599

Ziekenhuis Oost-LimburgIron Deficiency, Pulmonary Hypertension

Start: 2026-01-27End: 2028-10-01Target: 306Updated: 2026-01-30

Unknown Phase

Intertransverse Process Block to Improve Quality of Recovery After Cardiac Surgery With Sternotomy

Not yet recruitingNCT06926764

Chinese University of Hong KongAcute Postoperative Pain

Start: 2025-11-30End: 2027-11-30Target: 100Updated: 2025-04-16

Efficacy of Liberal Versus Restricted IV Fluid Approach in the Management of Sickle Cell Vaso-Occlusive Crisis

RecruitingNCT07188766

Imam Abdulrahman Bin Faisal UniversitySCD, Vaso Occlussive Crisis

Start: 2025-10-05End: 2028-10-01Target: 394Updated: 2026-03-18

Related Papers

Sitagliptin plus granulocyte colony-stimulating factor in patients suffering from acute myocardial infarction: A double-blind, randomized placebo-controlled trial of efficacy and safety (SITAGRAMI trial).

2015-11-3019 citations

Abstract 12114: Safety and Efficacy of Sitagliptin plus Granulocyte-colony Stimulating Factor in Patients Suffering From Acute Myocardial Infarction (Sitagrami Trial) - Primary and Secondary Analyses